[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 1978

Tendency of Fluorouracil to Conceal Deep Foci of Invasive Basal Cell Carcinoma

Author Affiliations

From the Chemosurgery Clinic, University of Wisconsin Medical Center, Madison (Drs Mohs and Bloom), and the Departments of Dermatology, Midelfort Clinic, Eau Claire, Wis (Dr Jones) and the University of Minnesota Medical School, Minneapolis (Dr Jones).

Arch Dermatol. 1978;114(7):1021-1022. doi:10.1001/archderm.1978.01640190009003

• Topical fluorouracil treatment of invasive basal cell carcinomas (BCC) is not recommended because it often produces the appearance of control with superficial inhibition of the tumor as the deeper extensions continue to grow, which results in a needless delay in obtaining effective treatment. These conclusions are based on data obtained during the microscopically controlled excision of 103 invasive BCCs of the face that had recurred after topical fluorouracil treatment.

(Arch Dermatol 114:1021-1022, 1978)